The nonclinical toxicologic profile of stavudine

Physicians Desk Reference

Ronald A. Arky · 1994 · 2.6K citations

Business, Marketing, Product Management +11

PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)

Robert Yarchoan · The Lancet · 1988 · 510 citations

Medicine, Infectious Diseases, Pharmacology +10

Potent and selective in vitro activity of 3' -deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus

Tai‐Shun Lin, Raymond F. Schinazi, William H. Prusoff · Biochemical Pharmacology · 1987 · 261 citations

Medicine, Medicinal Chemistry, Pharmacology +7

The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.

Jan Balzarini, Gil-Jong Kang, Maha Dalal et al. · Molecular Pharmacology · 1987 · 234 citations

Medicine, Medicinal Chemistry, Pharmacology +14

1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent

Muzammil M. Mansuri, John E. Starrett, Ismail Ghazzouli et al. · Journal of Medicinal Chemistry · 1989 · 212 citations

Medicine, Medicinal Chemistry, Pharmacology +8